Researchers at the University of California Davis have developed a method to spatially characterize and chemically analyze nanoparticles from biological and environmental samples for enhanced disease diagnosis and pollutant detection.

Researchers at the University of California, Davis have developed methods to create ergoline analogs that promote neuronal growth without hallucinogenic effects.

Researchers at the University of California, Davis have developed a gene therapy that selectively targets KSHV-infected tumors through virus-specific sequences and suicide genes to induce tumor cell death.

Researchers at the University of California, Davis have discovered FOXO inhibition using compounds such as AS1842856 dramatically enhances alpha-defensin expression in human intestinal organoids, restoring antimicrobial peptide levels comparable to native tissue.

Researchers at the University of California, Davis have developed a technology for the treatment of neuropsychiatric and neurological diseases with compounds that enhance neural plasticity without the hallucinogenic effects.

Researchers at the University of California, Davis have developed a machine learning-based platform for early, accurate, and efficient detection of endothelial disease from corneal images assessment.

Researchers at the University of California, Davis have developed an algorithm that uses data from group testing to rapidly provide lifestyle optimizations that improve the health of patients.

Researchers at the University of California, Davis, have developed a model to estimate biological and chronological age from blood serum samples.